JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Microbiology Section DOI : 10.7860/JCDR/2015/13189.6050
Year : 2015 | Month : Jun | Volume : 9 | Issue : 6 Full Version Page : DC01 - DC03

Fungal Culture Positivity in Patients with Perforation Peritonitis

Neerja Jindal1, Shilpa Arora2, Sumeet Pathania3

1 Professor and Head, Department of Microbiology, GGS Medical College and Hospital, Faridkot, India.
2 Assistant Professor, Department of Microbiology, GGS Medical College and Hospital, Faridkot, India.
3 Junior Resident, Department of Surgery, GGS Medical College and Hospital, Faridkot, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Shilpa Arora, St. No.1 Pratap Nagar, Kotkapura-151204, India. E-mail : s.arora49@yahoo.com
Abstract

Background

Perforation peritonitis is the most common surgical emergency. A large number of microorganisms have been cultured from the abdominal fluid obtained from patients with gastrointestinal perforation peritonitis. The present study was undertaken to determine the frequency of positive fungal culture in perforation peritonitis as Candida co-infection is reported to be a bad prognostic factor in these patients.

Materials and Methods

The intraoperative specimens of abdominal fluid collected during laparotomy from 140 condivutive patients of gastro-intestinal perforation were analysed by microbial culture for bacteria and fungi. Their antimicrobial susceptibility was also studied.

Results

The mean presenting age of the patients was 35 years and 120 (85.7%) of them were males. Aerobic Gram Negative Bacilli (AGNB) were observed in 82 (79.6%) of the culture positive abdominal fluid specimens, of which 58 (70.7%) were Escherichia coli. Gram negative bacteria were most frequently isolated from colorectal perforation (100%) while Gram positive bacteria were from upper gastrointestinal perforation (47.2%). Candida was cultured in as many as 68 of 140 (48.6%) specimens. Its prevalence was highest in patients with gastroduodenal perforation (70.5%) and was altogether absent in patients having appendicular perforation.

Conclusion

High prevalence of fungal culture positivity of peritoneal fluid of patients of perforation peritonitis shows that along with the bacterial culture, fungal cultures should always be asked for in such patients. Adequate and timely antimicrobial treatment including treatment of fungal infection could help reduce mortality in this group of patients.

Keywords

Introduction

Perforation peritonitis, the most common surgical emergency is associated with a high degree of morbidity and mortality. The reported mortality rate ranges between 17% and 63% [16]. The contaminating micro-organisms responsible for peritonitis with hollow viscous perforation are frequently polymicrobial and diverse [7]. Until recently, the leading pathogens were gram negative bacilli and anaerobic bacteria [8]. Of late, fungal micro-organisms (Candida) are being reported with increasing frequency [9]. Different studies show that the prevalence of different micro-organisms in intestinal perforation peritonitis varies with geographical area, patient profile and location of the perforation. As there is a paucity of similar studies from North-west Punjab, the present study was undertaken to determine the frequency of positive fungal culture and other micro-organisms involved in perforation peritonitis. This would help in the early initiation of adequate management of these patients.

Materials and Methods

The study was conducted on 140 consecutive patients of gastro-intestinal perforation admitted during the period of two and a half years (January 2011 to June 2013) in Guru Gobind Singh Medical College & Hospital, Faridkot, India, after taking approval from the ethical committee. The inclusion criterion was any patient undergoing exploratory laparotomy for gastro-intestinal perforation except for those who presented with primary peritonitis or peritonitis due to trauma, patients on antifungal treatment before the surgery and patients less than 5 years of age. Preoperative clinical factors recorded were duration of fever, duration of abdominal pain, preoperative use of antibiotics, Preoperative medical conditions, preexisting malignancy and history of drug addiction.

Microbiological sampling

The intraoperative specimens of abdominal fluid were collected during laparotomy in sterile containers using all aseptic precautions. The specimens were immediately transferred to microbiology laboratory. In the laboratory, culture for aerobic bacteria and fungi was done. For bacterial isolation Blood agar and MacConkey agar was used and the plates were incubated at 37°C for 24 hours. Cultures positive for bacterial growth were identified by standard microbiological methods. Antimicrobial susceptibility of the identified bacteria was performed by using Kirby Bauer Disc Diffusion method following CLSI guidelines [10].

Sabouraud dextrose agar (SDA) was used as selective medium for isolation of fungi and incubation was done at 37°C for 48 hours. Lactophenol Cotton Blue mount showing budding yeast cells from the colonies obtained on SDA were identified by conventional methods such as germ tube test, sugar fermentation and assimilation reactions. Further confirmation of Candida species and their antifungal susceptibility was done by using automated identification and antimicrobial susceptibility testing system ‘Vitek-2 Compact’ (bioMerieux). Data thus obtained was compiled and results were statistically analysed using Chi-square test.

Results

Preoperative profile of 140 patients enrolled in the study is shown in [Table/Fig-1]. The mean presenting age of the patients was 35 years (SD 13.0). Majority of the patients (93.6%) were less than 50 years of age. One hundred and twenty (85.7%) were males and 20 (14.3%) were females. Most common comorbid condition was renal disease (12.9%) followed by drug dependence (10.7%). The [Table/Fig-2] shows that the anatomic locations of the perforations were as follows: gastroduodenal 68 (48.6%); small gut 55 (39.3%); appendicular 9 (6.4%) and large gut 8 (5.7%).

Preoperative profile of 140 patients

ParametersNumber of patients (%)
Age
<50 years131 (93.6)
>50 years9 (6.4)
Sex
Male120 (85.7)
Female20 (14.3)
Pre- existing comorbid conditions
Hypertension6 (4.3)
Diabetes mellitus14 (10)
Renal disease18 (12.9)
Ischaemic heart disease3 (2.1)
HIV infection3 (2.1)
Chronic alcoholism5 (3.6)
Drug dependence15 (10.7)

Microbiological data

Of the 140 abdominal fluid samples cultured, 103 (73.5%) were found to be positive for various bacteria and/or fungi and 37 (26.5%) were sterile. Sixty of the 103 (58.2%) specimens showed growth of multiple microorganisms; pure growth of Candida was obtained in 9 (8.7%).

The type of microorganisms isolated varied as per location of the perforation [Table/Fig-2]. In all, aerobic Gram Negative Bacilli (AGNB) were observed in 82 (79.6%) of the 103 culture positive abdominal fluid specimens, of which 58 (70.7%) were Escherichia coli. The gram negative bacteria were most frequently isolated from colorectal perforations 100% (8/8) followed by perforated appendicitis 88.9% (8/9). The results of their antimicrobial susceptibility showed that all the (100%) AGNB isolates were susceptible to aminoglycosides and 50% each to piperacillin-tazobactam and cefoperazone-sulbactam. But no strain was found to be susceptible to any of the quinolones and cephalosporins.

Microorganisms isolated as per location of perforation

Percentage in parenthesis

MicroorganismLocation of perforationTotal
Upper (gastroduodenal, jejunal and ileal) n=123Lower (large gut) n=8Appendicitis n=9
AGNBN=66 (53.6%)N=8(100%)N=8(88.9%)82
E. coli48(39%)5(62.5%)5(55.5%)58
Klebsiella17(13.8%)1(12.5%)1(11.1%)19
Enterobacter--2(22.2%)2
Pseudomonas-2(25%)-2
GPC58(47.2%)3(37.5%)3(33.3%)64
Yeast66(53.6%)2(25%)-68
C.albicans51(41.5%)1(12.5%)-52
Non albicans Candida15(12.1%)1(12.5%)-16
C. krusei8(6.5%)1(12.5%)
C. tropicalis4(3.2%)
C. glabrata3(2.4%)

Gram positive bacteria were cultured most frequently from upper gastrointestinal perforations 47.2% (58/123). No strain was resistant to vancomycin. The susceptibility was highest against aminoglycosides (100%) followed by ciprofloxacin (78%) and erythromycin (72%).

Candida was cultured in as many as 68 of 140 (48.6%) specimens. The prevalence of Candida in abdominal fluid cultures was highest in patients with gastroduodenal perforation 70.5% (48/68) followed by small intestinal perforation 32.8% (18/55). It was not at all isolated from specimens of patients having appendicular perforation. It was obtained in combination with various bacteria in 59 (57.2%) of the culture positive specimens and as pure growth in 9 (8.7%). Their speciation showed that 52 (76.5%) of the Candida isolates were C. albicans and 16 (23.5%) were non albicans Candida species. Various non albicans candida species were C. krusei 8 (6.5%), C. tropicalis 4 (3.2%) and C. glabrata 3 (2.4%). All the Candida albicans, C.tropicalis and C. glabrata isolates were sensitive to fluconazole, flucytosine, amphotericin B, caspofungin and voriconazole. C. krusei was also found to be sensitive to these antifungal agents except fluconazole (inherent resistance).

Relationship of fungal culture to surgical site infection, residual abscess, ICU stay, hospital stay and mortality is shown in [Table/Fig-3].

Relationship of fungal culture to various parameters

VariablesFungal positive (n=68)Fungal negative (n=72)p-value
No.%ageNo.%age
Superficial Surgical Site Infection*5276.52940.3< 0.0001
Deep Surgical Site Infection#4058.81825< 0.0001
Residual Abscess$1826.545.60.0009
ICU stay (>5 days)2841.21013.90.0003
Hospital stay (>15 days)4972.12230.6< 0.0001
Mortality1014.722.80.0148

*Involving only skin and subcutaneous tissue of the incision

#involving deep soft tissue (fascia, muscle) of the incision

$Abscess recurring at the site of a former abscess resulting from persistence of microbes and pus


Discussion

Perforation peritonitis is a frequently encountered surgical emergency. In tropical countries like India, it commonly affects young men in the prime of life in comparison to the studies from the west [11] where the mean age is between 45–60 years. The mean presenting age in the present study was 35 years (SD 13) which collaborates with another study from India [12]. Worldwide there is predominance of males presenting with this life-threatening problem [1214]; our study also shows a similar trend, with a male to female ratio of 6:1.

The gastrointestinal tract is a major reservoir of microorganisms and an important portal for intra abdominal infections and sepsis. Results of the present study revealed that the composition of the microbial flora in the abdominal fluid varied depending on the location of the perforation. From the upper gastrointestinal perforation high prevalence of AGNB (53.6%) & GPC (47.2%) was observed along with 53.6% prevalence of Candida. From the lower digestive tract more of AGNB (100%) and GPC (37.5%) were isolated than Candida (25%). Candida was not isolated from appendicular perforation. These results are in concordance with the study of Ruiter et al., who had also reported maximum isolation of Candida from gastric perforation (41%) followed by small gut perforation (34.1%) [15]. Candida was not isolated from appendicular perforation in their study too.

In all, Candida was recovered from as many as 48.6% (68/140) of intraoperative intra-abdominal specimens. The isolation rate of Candida in different studies varies considerably. Candida has apparently not been detected in some of the studies [16,17] while in others their isolation rate ranged from 1% to 38% of patients with secondary peritonitis [1,2,1820]. The differences in the rate of fungal isolation in different studies could be because of different patient populations studied, differences in the microbiological methods used for the isolation of fungus or a combination of both. There are two important reasons for the high recovery rate of Candida in our study. Firstly, all the specimens were cultivated on a selective yeast medium (Sabouraud’s Agar). Specimens of peritoneal fluid after an abdominal perforation nearly always consist of a mixture of different aerobic and anaerobic bacteria and in such situations, the isolation of Candida may easily be missed if only culture media for bacterial isolation are used. Secondly, majority of our patients reported history of long duration of intake of antibiotics. Prolonged treatment with broad spectrum antibiotics gives the yeasts (Candida) a further growth advantage.

As a commensal of the digestive tract, Candida may leak into the peritoneal cavity after perforation of a hollow viscus or surgical section of the intestinal wall. However, under most circumstances, Candida will be cleared quickly from the peritoneum. Nevertheless, in some patients, peritoneal seeding could result in the development of an intra-abdominal Candida infection, with a risk of dissemination to the bloodstream and to extra-abdominal tissues and organs [21].

The question remains of whether routine antifungal therapy would benefit the patients with perforation peritonitis. In our study, patients with positive fungal culture had higher incidence of surgical site infection, residual abscess formation, longer ICU stay, longer hospital stay and higher mortality rates in comparison to fungal culture negative patients and results were statistically significant (p- value = <0.0001, <0.0001, 0.0009, 0.0003, <0.0001, 0.0148 respectively). These patients may be considered for early antifungal therapy which could minimise the overall morbidity and mortality. However, as Candida was not at all isolated in appendicular perforation, this suggests that Candida is not an important pathogen in appendicitis and antifungal treatment is unnecessary in perforated appendicitis. This is in agreement with other studies too [15,22]. Here it is important to mention that before initiating antifungal treatment, the isolated candida strain should be speciated and subjected to antifungal susceptibility testing as some of the species (e.g. C krusei) are inherently resistant to azoles.

Conclusion

It can thus be concluded that bacterial as well as fungal cultures and antimicrobial sensitivities of peritoneal fluid specimens are imperative for the treatment of patients of perforation peritonitis. As there is high prevalence of positive peritoneal fluid fungal cultures and fungus being a significant risk factor for adverse outcome in these patients, surgeons should be made aware of the usefulness of the prophylactic antifungal therapy, especially in patients with upper gastrointestinal perforation.

References

[1]Wacha H, Hau T, Dittmer R, Ohmann C, Risk factors associated with intra-abdominal infections: a prospective multicenter study. Peritonitis Study Group Langenbecks Arch Surg 1999 384(1):24-32.  [Google Scholar]

[2]Pacelli F, Doglietto GB, Alfieri S, Piccioni E, Sgadari A, Gui D, Crucitti F, Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients Arch Surg 1996 131(6):641-45.  [Google Scholar]

[3]Barie PS, Hydo LJ, Eachempati SR, Longitudinal outcomes of intra-abdominal infection complicated by critical illness Surg Infect (Larchmt) 2004 5(4):365-73.  [Google Scholar]

[4]Schoeffel U, Jacobs E, Ruf G, Mierswa F, von Specht BU, Farthmann EH, Intraperitoneal micro-organisms and the severity of peritonitis Eur J Surg 1995 161(7):501-08.  [Google Scholar]

[5]Christou NV, Barie PS, Dellinger EP, Waymack JP, Stone HH, Surgical Infection Society intra-abdominal infection study. Prospective evaluation of management techniques and outcome Arch Surg 1993 128(2):193-8.discussion 198-89  [Google Scholar]

[6]McLauchlan GJ, Anderson ID, Grant IS, Fearon KC, Outcome of patients with abdominal sepsis treated in an intensive care unit Br J Surg 1995 82(4):524-29.  [Google Scholar]

[7]Blot S, De Waele JJ, Critical issues in the clinical management of complicated intra-abdominal infections Drugs 2005 65(12):1611-20.  [Google Scholar]

[8]Wittmann DH, Schein M, Condon RE, Management of secondary peritonitis Ann Surg 1996 224(1):10-18.  [Google Scholar]

[9]Wallace WC, Cinat ME, Nastanski F, Gornick WB, Wilson SE, New epidemiology for postoperative nosocomial infections Am Surg 2000 66(9):874-78.  [Google Scholar]

[10]Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; twenty first informational supplement M100-S21. Wayne: Clinical and Laboratory Standards Institute; 2011  [Google Scholar]

[11]Svanes C, Salvesen H, Espehaug B, Søreide O, Svanes K, A multifactorial analysis of factors related to lethality after treatment of perforated gastroduodenal ulcer. 1935-1985 Ann Surg 1989 209(4):418-23.  [Google Scholar]

[12]Jhobta RS, Attri AK, Kaushik R, Sharma R, Jhobta A, Spectrum of perforation peritonitis in India--review of 504 consecutive cases World J Emerg Surg 2006 1:26  [Google Scholar]

[13]Wani RA, Parray FQ, Bhat NA, Wani MA, Bhat TH, Farzana F, Nontraumatic terminal ileal perforation World J Emerg Surg 2006 1:7  [Google Scholar]

[14]Memon AA, Siddiqui FG, Abro AH, Agha AH, Lubna S, Memon AS, An audit of secondary peritonitis at a tertiary care university hospital of Sindh, Pakistan World J Emerg Surg 2012 7:6  [Google Scholar]

[15]de Ruiter J, Weel J, Manusama E, Kingma WP, van der Voort PH, The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis Infection 2009 37(6):522-27.  [Google Scholar]

[16]Basoli A, Meli EZ, Mazzocchi P, Speranza V, Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections:results of a prospective, randomized, multicentre trial Scand J Infect Dis 1997 29(5):503-08.  [Google Scholar]

[17]Ohlin B, Cederberg A, Forssell H, Solhaug JH, Tveit E, Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections Eur J Surg 1999 165(9):875-84.  [Google Scholar]

[18]Christou NV, Turgeon P, Wassef R, Rotstein O, Bohnen J, Potvin M, Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-abdominal Infection Study Group Arch Surg 1996 131(11):1193-201.  [Google Scholar]

[19]Farthmann EH, Schöffel U, Epidemiology and pathophysiology of intra-abdominal infections (IAI) Infection 1998 26(5):329-34.  [Google Scholar]

[20]Koperna T, Schulz F, Relaparotomy in peritonitis: prognosis and treatment of patients with persisting intra-abdominal infection World J Surg 2000 24(1):32-37.  [Google Scholar]

[21]Calandra T, Marchetti O, Clinical trials of antifungal prophylaxis among patients undergoing surgery Clin Infect Dis 2004 39:S185-92.  [Google Scholar]

[22]Sandven P, Qvist H, Skovlund E, Giercksky KE, NORGAS Group and the Norwegian Yeast Study Group. Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations Crit Care Med 2002 30(3):541-47.  [Google Scholar]